Benzinga

Benzinga

Benzinga

lunes, septiembre 07

Biodexa Pharmaceuticals PLC

BDRXNASDAQ
Trade with Public
Trade with Public
$0.8480
0.04966.21%
al cierre: Sep 4, 5:00 PM EST
$0.7789
-0.0691-8.15%
After hour: Sep 4, 8:42 AM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoCompararInforme de acciones

Biodexa Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Biodexa Pharmaceuticals (BDRX).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$8Upside to Avg. PT+927.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Feb 8, 2024Ladenburg ThalmannAydin HuseynovInitiateBuy$8

Analyst Ratings News

PRO
Watching Biodexa Pharmaceuticals; Zacks Small-Cap Research Gives Stock $10 Price Valuation

Benzinga Newsdesk

PRO
Ladenburg Thalmann Initiates Coverage On Biodexa Pharmaceuticals with Buy Rating, Announces Price Target of $8

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Biodexa Pharmaceuticals (NASDAQ:BDRX) with a Buy rating and announces Price Target of $8.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved